|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 9 studies with search of: | glioblastoma AND gefitinib |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
A Phase II Exploratory, Multicentre, Open-Label, Non-Comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme
|
||||
| 2 | Completed |
Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research
|
||||
| 3 | Active, not recruiting |
Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer
|
||||
| 4 | Active, not recruiting |
Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
|
||||
| 5 | Completed |
Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
||||
| 6 | Completed |
ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse
|
||||
| 7 | Completed |
Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
|
||||
| 8 | Recruiting |
ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
|
||||
| 9 | Completed |
Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma
|